Technetium and Rhenium in Nuclear Medicine
Technetium and Rhenium in Nuclear Medicine
批准号:
7186633
负责人:
Alun Gareth Jones
金额:
$56.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-02-01 至 2010-12-31
关键词:
AffinityAnimal ModelAreaBehaviorBiological AssayBrainChemicalsChemistryClinicClinicalComplexCountryCoupledDevelopmentDiscipline of Nuclear MedicineDiseaseEvaluationGrowthHuman bodyImageImaging TechniquesLigandsLongitudinal StudiesLungMalignant NeoplasmsMalignant neoplasm of prostateMetalsMonitorNeuraxisNeurotransmittersNew AgentsPlayPliabilityPublic HealthPurposeRadioisotopesResearchResolutionRheniumRoleSystemTechnetiumTimeWorkbasedesignin vivoin vivo Modelmelanomapreclinical studypreferenceprogramsreceptortumortumor growthuptake
中文摘要
描述(由申请人提供):本提案中描述的研究是基于99mTc在常规临床核医学实践中仍将是重要放射性核素的前提下的项目的延续。主要的重点是在两个领域开发新的药剂,加上一些精心挑选的化学研究,旨在增加产品复合物设计的灵活性,从而提高其生物行为。第一个主要目的是继续评估能够检测体内恶性黑色素瘤存在的锝复合物。在目前的周期中,已经确定了几种潜在的候选药物在黑色素瘤动物模型中表现出显著的摄取,包括一种转移性扩散到肺部的黑色素瘤。一种新的高分辨率微spect相机现在已经使纵向研究成为可能,允许随时间监测肿瘤生长,这是一种非常有用的能力,将在拟议的时期进一步追求。第二个主要目标是继续设计对5HT1A受体具有亲和力的复合物。在过去的几年里,人们越来越清楚地认识到,除了它们在中枢神经系统中的既定功能外,神经递质系统在整个人体的癌症生长和扩散中起着重要作用。因此,计划测定正常脑和体内前列腺癌模型的摄取情况,前列腺癌是表达这种受体类型的肿瘤的一个例子。寻找对5HT1A受体具有高亲和力和选择性的复合物的重要性随着研究的重要双重目的的前景而增加。第三个主要目的是研究两种金属核的化学行为和配体偏好,作为目标1和目标2中使用的Tc/Re(V)氧核的替代品:研究相对较好的Tc(l)三羰基核和研究较少的Tc(l)亚硝基核。这种化学反应将支持目标1和目标2中的工作,因为后一种核心应该在最终平台的设计中提供更大的灵活性,以安装给定的生物活性部分。恶性黑色素瘤和前列腺癌都是我国严重的公共卫生问题。这项工作的目的是开发一种在临床使用无创成像技术检测这些肿瘤的方法。小动物模型的显微spect成像能力在评估这些疾病新疗法发展的临床前研究中也很有用。
英文摘要
DESCRIPTION (provided by applicant): The research described in this proposal is the continuation of a program based on the premise that 99mTc will remain an important radionuclide in the practice of routine clinical nuclear medicine. The primary thrust is the development of new agents in two areas, coupled with some carefully selected chemical studies intended to add flexibility in the design of the product complexes and, thus, their biologic behavior. The first major aim is to continue the evaluation of technetium complexes capable of detecting the presence of malignant melanoma in vivo. Over this current cycle, several potential candidates have been identified as showing significant uptake in animal models of melanoma, including one of metastatic spread to the lungs. A new high resolution microSPECT camera has now made possible longitudinal studies that allow monitoring of tumor growth with time, a highly useful capability that will be pursued further in the proposed period. The second major aim is to continue designing complexes that have affinity for the 5HT1A receptor. Over the past few years it has become increasingly clear that, apart from their established function in the central nervous system, neurotransmitter systems play a significant role in the growth and spread of cancer throughout the human body. Thus, it is planned to assay uptake in both normal brain and in vivo models of prostate cancer, an example of tumors that express this receptor type. The search for complexes with high affinity and selectivity for 5HT1A receptors increases in importance with the prospect of important dual purposes for the research. The third major aim is to examine the chemical behavior and ligand preferences of two metal cores as alternatives to the Tc/Re(V) oxo core used in aims 1 and 2: the relatively well-studied Tc(l) tricarbonyl core and the less well-explored Tc(l) nitrosyl core. This chemistry will be conducted in support of the work in aims 1 and 2 in that the latter cores should provide more flexibility in the design of the final platform for mounting a given biologically active moiety. Malignant melanoma and prostate cancer are both serious public health problems in this country. This work is designed to develop a means of detecting these tumors in the clinic using noninvasive imaging techniques. The microSPECT imaging capability with small-animal models could also prove useful in preclinical studies assessing the development of new therapies for these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:2088804
-
项目类别:
-
资助金额:$53.07万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:2633759
-
项目类别:
-
资助金额:$53.67万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
THE CHEMISTRY OF TECHNETIUM RELATED TO NUCLEAR MEDICINE
-
批准号:3172756
-
项目类别:
-
资助金额:$37.6万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:6512439
-
项目类别:
-
资助金额:$49.34万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
Technetium and Rhenium in Nuclear Medicine
-
批准号:7342139
-
项目类别:
-
资助金额:$56.39万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
THE CHEMISTRY OF TECHNETIUM RELATED TO NUCLEAR MEDICINE
-
批准号:3172758
-
项目类别:
-
资助金额:$37.81万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
THE CHEMISTRY OF TECHNETIUM RELATED TO NUCLEAR MEDICINE
-
批准号:3172757
-
项目类别:
-
资助金额:$37.29万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
THE CHEMISTRY OF TECHNETIUM RELATED TO NUCLEAR MEDICINE
-
批准号:3172755
-
项目类别:
-
资助金额:$21.38万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:2856237
-
项目类别:
-
资助金额:$55.13万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:3482296
-
项目类别:
-
资助金额:$48.2万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:3482295
-
项目类别:
-
资助金额:$48.39万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
Technetium and Rhenium in Nuclear Medicine
-
批准号:7049207
-
项目类别:
-
资助金额:$59.84万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:6632909
-
项目类别:
-
资助金额:$50.55万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
Technetium and Rhenium in Nuclear Medicine
-
批准号:7743729
-
项目类别:
-
资助金额:$58.79万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:2088803
-
项目类别:
-
资助金额:$49.26万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
Technetium and Rhenium in Nuclear Medicine
-
批准号:7540984
-
项目类别:
-
资助金额:$57.85万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:2088805
-
项目类别:
-
资助金额:$55.18万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
THE CHEMISTRY OF TECHNETIUM RELATED TO NUCLEAR MEDICINE
-
批准号:3172754
-
项目类别:
-
资助金额:$60.54万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:2007405
-
项目类别:
-
资助金额:$54.03万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
-
批准号:6375667
-
项目类别:
-
资助金额:$48.16万
-
财政年份:1977
-
负责人:Alun Gareth Jones
-
依托单位:
海外基金